Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by Keeleron May 10, 2024 1:06pm
57 Views
Post# 36033911

Quinlash - you and your fellow longs

Quinlash - you and your fellow longs

and paid promoters are the ones who raise Cura - as you did in making the irrelevant comparison between CEOs.
I say moly respond to your nonsensical posts.

Tilray DID show an increase - too bad it wasn't organic, core business actually saw a decrease in sales.
ANY company will show an increase in sales by spending $250 to acquire bankrupt Hexo - and $85 million USD to acquire failing craft brewers. )although they got SERO growth for the $225 million spent on bankrupt Medmen)

unfortunately for Tilray investors - top line sales increased - gross margin dropped from approx 45% to 34% - less gross orders t because Tilray can't control their cost of goods sold.

Curaleaf revenue has increased organically - despite your false post- and they achieve $2 billion in annual revenue.
Tilray HASNT hit $800 million yet - despite Simple Simon stating they would show $4 billion for 2024.

 

Post by quinlashon May 10, 2024 9:54am
56 Views 
Post# 36033321

QTR Reports TLRY vs CURA

Cura reported s 2% year over year increase in revenue while Tilray reported 30%

Stop promoting CURA on the Tilray forum.  There's a reason some of us are accumulating on this one and not CURA 

Tilray's Latest report summary

<< Previous
Bullboard Posts
Next >>